Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

acetylglucosaminyltransferase V inhibitor PhOx430

An inhibitor of the glycosyltransferase N-Acetylglucosaminyltransferase V (GnT-V), with potential antineoplastic activity. Upon administration, GnT-V inhibitor PhOx430 targets, binds to and inhibits the activity of GnT-V, a glycosylation enzyme that synthesizes the beta1, 6-GlcNAc branch in N-glycans. This inhibits the glycosylation of tumor cells and downregulates cell surface receptors implicated in tumor cell growth and metastasis. GnT-V and its product N-glycans, upregulated in various types of cancer cells, are associated with cancer proliferation and metastasis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:GnT-V inhibitor PhOx430
N-acetylglucosaminyltransferase V inhibitor PhOx430
Code name:PhOx 430
PhOx-430
PhOx430
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search